⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT May 12, 2026

Praluent 75 mg Injektionslösung in einem Fertigpen 75 mg (Injektionslösung im Fertigpen)

📷 EU Safety Watch placeholder
Praluent 75 mg Injektionslösung in einem Fertigpen 75 mg (Injektionslösung im Fertigpen)
📷 EU Safety Watch placeholder
Praluent 75 mg injection solution in a pre-filled pen 75 mg Parallel export ban in effect. Reason: increased additional demand. Marketing authorisation holder: Sanofi Winthrop Industrie, Gentilly, France. Affected packs: 2-pen box unavailable since 5 May 2026, resupply 1 June 2026; 1-pen box available.
⚠️
Shortage ongoing
ALIROCUMAB is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? Praluent is a medicine given by injection. It helps lower bad cholesterol in the blood.

What's happening? One pack size of Praluent is not available right now. The other pack size can still be bought.

Does this affect me? If you use Praluent, check which pack you have. The shortage may affect you if you need the unavailable pack.

What should I do? Ask your pharmacist or doctor for advice before changing your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
ALIROCUMAB
Agency-published detail

🚫 Parallel export ban active · ATC: C10 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Sanofi Winthrop Industrie, 82 Avenue Raspail -, 94250 Gentilly, French Republic · Affected packs: 2 Stück Schachtel, Fertigpen [Nicht verfügbar, since 2026-05-05, resupply 2026-06-01] · 1 Stück Schachtel, Fertigpen [verfügbar]

First published
May 12, 2026
Last refreshed by us
15 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Praluent 75 mg Injektionslösung in einem Fertigpen 75 mg (Injektionslösung im Fertigpen). Praluent 75 mg injection solution in a pre-filled pen 75 mg Parallel export ban in effect. Reason: increased additional demand. Marketing authorisation holder: Sanofi Winthrop Industrie, Gentilly, France. Affected packs: 2-pen box unavailable since 5 May 2026, resupply 1 June 20...
▸ When was this alert issued?
This alert was issued on May 12, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.